Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1571.HK Stock Summary
Top 10 Correlated ETFs
1571.HK
In the News
1571.HK Financial details
Company Rating
Buy
Market Cap
2.94B
Income
522.75M
Revenue
3.09B
Book val./share
3.22
Cash/share
0.66
Dividend
0.24
Dividend %
8.6%
Employees
5.67K
Optionable
No
Shortable
Yes
Earnings
26 Mar 2024
P/E
5.95
Forward P/E
5.2
PEG
0.4
P/S
0.89
P/B
0.88
P/C
4.8
P/FCF
9.09
Quick Ratio
0.39
Current Ratio
2.26
Debt / Equity
0.08
LT Debt / Equity
0.05
-
-
EPS (TTM)
0.52
EPS next Y
0.61
EPS next Q
-
EPS this Y
104.76%
EPS next Y
17.31%
EPS next 5Y
17.31%
EPS last 5Y
1.97%
Revenue last 5Y
7.06%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
7.14%
SMA50
8.7%
SMA100
5.63%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
16%
ROC
0.17%
Gross Margin
31%
Oper. Margin
19%
Profit Margin
15%
Payout
16%
Shs Outstand
1B
Shs Float
259.43M
-
-
-
-
Target Price
-
52W Range
2.21-3.17
52W High
+5.67%
52W Low
+58.5%
RSI
65.88
Rel Volume
2.98
Avg Volume
204.07K
Volume
609K
Perf Week
7.09%
Perf Month
21.92%
Perf Quarter
16.97%
Perf Half Y
10.84%
-
-
-
-
Beta
1.01
-
-
Volatility
0.1%, 0.14%
Prev Close
1.93%
Price
3.17
Change
-3.94%
1571.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.04 | 2.12 | 2.06 | 2.31 | 2.87 | |
Net income per share | 0.39 | 0.2 | 0.33 | 0.21 | 0.43 | |
Operating cash flow per share | 0.35 | 0.46 | 0.41 | 0.13 | 0.45 | |
Free cash flow per share | -0.2 | 0.08 | 0.25 | -0.29 | 0.28 | |
Cash per share | 0.52 | 0.58 | 0.63 | 0.16 | 0.36 | |
Book value per share | 2.24 | 2.35 | 2.44 | 2.47 | 2.91 | |
Tangible book value per share | 2.17 | 2.34 | 2.44 | 2.46 | 2.91 | |
Share holders equity per share | 2.24 | 2.35 | 2.44 | 2.47 | 2.91 | |
Interest debt per share | 0.01 | 0.11 | 0.15 | 0.28 | 0.29 | |
Market cap | 2.35B | 1.95B | 4.01B | 2.13B | 1.99B | |
Enterprise value | 1.83B | 1.59B | 3.62B | 2.25B | 1.93B | |
P/E ratio | 5.95 | 9.5 | 12.06 | 9.89 | 4.62 | |
Price to sales ratio | 1.15 | 0.92 | 1.94 | 0.92 | 0.69 | |
POCF ratio | 6.58 | 4.22 | 9.75 | 15.73 | 4.44 | |
PFCF ratio | -11.44 | 25.06 | 15.74 | -7.38 | 7.06 | |
P/B Ratio | 1.04 | 0.83 | 1.64 | 0.86 | 0.68 | |
PTB ratio | 1.04 | 0.83 | 1.64 | 0.86 | 0.68 | |
EV to sales | 0.89 | 0.75 | 1.75 | 0.97 | 0.67 | |
Enterprise value over EBITDA | 3.19 | 4.09 | 6.7 | 5.27 | 2.65 | |
EV to operating cash flow | 5.13 | 3.44 | 8.79 | 16.66 | 4.29 | |
EV to free cash flow | -8.93 | 20.46 | 14.19 | -7.81 | 6.83 | |
Earnings yield | 0.17 | 0.11 | 0.08 | 0.1 | 0.22 | |
Free cash flow yield | -0.09 | 0.04 | 0.06 | -0.14 | 0.14 | |
Debt to equity | 0 | 0.04 | 0.06 | 0.11 | 0.09 | |
Debt to assets | 0 | 0.03 | 0.05 | 0.08 | 0.07 | |
Net debt to EBITDA | -0.9 | -0.92 | -0.73 | 0.29 | -0.09 | |
Current ratio | 2.59 | 2.21 | 2.45 | 1.89 | 2.26 | |
Interest coverage | 7.6K | 63.56 | 90.61 | 65.95 | 48.34 | |
Income quality | 0.76 | 1.96 | 1.18 | 0.53 | 0.87 | |
Dividend Yield | 0.06 | 0.07 | 0.03 | 0.07 | 0.04 | |
Payout ratio | 0.34 | 0.64 | 0.38 | 0.71 | 0.16 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Research and developement to revenue | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
Intangibles to total assets | 0.02 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.57 | -0.83 | -0.38 | -3.13 | -0.37 | |
Capex to revenue | -0.27 | -0.18 | -0.08 | -0.18 | -0.06 | |
Capex to depreciation | -5.45 | -2.54 | -0.89 | -2.46 | -0.88 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.44 | 3.29 | 4.27 | 3.45 | 5.31 | |
ROIC | 0.17 | 0.08 | 0.13 | 0.07 | 0.13 | |
Return on tangible assets | 0.14 | 0.06 | 0.1 | 0.06 | 0.11 | |
Graham Net | 0.64 | 0.43 | 0.55 | -0.02 | 0.21 | |
Working capital | 1.08B | 913.21M | 1.04B | 723.84M | 1.1B | |
Tangible asset value | 2.18B | 2.35B | 2.44B | 2.47B | 2.94B | |
Net current asset value | 1.07B | 839.62M | 976.68M | 611.36M | 933.65M | |
Invested capital | 0 | 0.04 | 0.06 | 0.11 | 0.09 | |
Average receivables | 697.7M | 668.62M | 624.95M | 629.24M | 703.06M | |
Average payables | 207.46M | 244.09M | 267.64M | 313.76M | 374.27M | |
Average inventory | 413.25M | 471.23M | 438.08M | 499.53M | 582.1M | |
Days sales outstanding | 130.58 | 103.45 | 113.94 | 96.67 | 100.49 | |
Days payables outstanding | 62.18 | 62.72 | 70.62 | 78.23 | 71.06 | |
Days of inventory on hand | 140.2 | 104.2 | 113.86 | 123.36 | 109.1 | |
Receivables turnover | 2.8 | 3.53 | 3.2 | 3.78 | 3.63 | |
Payables turnover | 5.87 | 5.82 | 5.17 | 4.67 | 5.14 | |
Inventory turnover | 2.6 | 3.5 | 3.21 | 2.96 | 3.35 | |
ROE | 0.18 | 0.09 | 0.14 | 0.09 | 0.15 | |
Capex per share | -0.56 | -0.38 | -0.16 | -0.42 | -0.17 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.78 | 0.78 | 0.76 | 0.76 | |
Net income per share | 0 | 0.13 | 0.13 | 0.13 | 0.13 | |
Operating cash flow per share | 0 | 0.11 | 0.11 | 0.24 | 0.24 | |
Free cash flow per share | 0 | 0.11 | 0.11 | 0.15 | 0.15 | |
Cash per share | 0 | 0.36 | 0.36 | 0.66 | 0.66 | |
Book value per share | 0 | 2.91 | 2.91 | 3.22 | 3.22 | |
Tangible book value per share | 0 | 2.91 | 2.91 | 3.22 | 3.22 | |
Share holders equity per share | 0 | 2.91 | 2.91 | 3.22 | 3.22 | |
Interest debt per share | 0 | 0.07 | 0.28 | 0.07 | 0.26 | |
Market cap | 0 | 1.87B | 1.99B | 2.19B | 2.36B | |
Enterprise value | 62.29M | 1.53B | 1.93B | 1.55B | 1.98B | |
P/E ratio | 0 | 3.61 | 3.85 | 4.16 | 4.48 | |
Price to sales ratio | 0 | 2.38 | 2.53 | 2.89 | 3.12 | |
POCF ratio | 0 | 16.44 | 17.5 | 9.2 | 9.92 | |
PFCF ratio | 0 | 17.51 | 18.63 | 14.25 | 15.36 | |
P/B Ratio | 0 | 0.64 | 0.68 | 0.68 | 0.73 | |
PTB ratio | 0 | 0.64 | 0.68 | 0.68 | 0.73 | |
EV to sales | 0 | 1.95 | 2.45 | 2.05 | 2.62 | |
Enterprise value over EBITDA | 0 | 8.3 | 10.45 | 8.64 | 11.03 | |
EV to operating cash flow | 0 | 13.44 | 16.92 | 6.51 | 8.32 | |
EV to free cash flow | 0 | 14.31 | 18.01 | 10.08 | 12.88 | |
Earnings yield | 0 | 0.07 | 0.06 | 0.06 | 0.06 | |
Free cash flow yield | 0 | 0.06 | 0.05 | 0.07 | 0.07 | |
Debt to equity | 0.08 | 0.02 | 0.09 | 0.02 | 0.08 | |
Debt to assets | 0.06 | 0.02 | 0.07 | 0.02 | 0.06 | |
Net debt to EBITDA | 0 | -1.85 | -0.36 | -3.57 | -2.13 | |
Current ratio | 2.01 | 2.26 | 2.26 | 2.29 | 2.29 | |
Interest coverage | 0 | 0 | 19.44 | 0 | 22.37 | |
Income quality | 0 | 0.88 | 0.88 | 1.81 | 1.81 | |
Dividend Yield | 0 | 0.02 | 0.02 | 0 | 0 | |
Payout ratio | 0 | 0.27 | 0.27 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.11 | 0.11 | 0.13 | 0.13 | |
Research and developement to revenue | 0 | 0.02 | 0.02 | 0.03 | 0.03 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | -0.06 | -0.06 | -0.35 | -0.35 | |
Capex to revenue | 0 | -0.01 | -0.01 | -0.11 | -0.11 | |
Capex to depreciation | 0 | -0.13 | -0.13 | -1.55 | -1.55 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 2.91 | 2.91 | 3.09 | 3.09 | |
ROIC | 0 | 0.04 | 0.04 | 0.03 | 0.03 | |
Return on tangible assets | 0 | 0.03 | 0.03 | 0.03 | 0.03 | |
Graham Net | 0 | 0.21 | 0.21 | 0.38 | 0.38 | |
Working capital | 832.19M | 1.1B | 1.1B | 1.28B | 1.28B | |
Tangible asset value | 2.67B | 2.92B | 2.94B | 3.23B | 3.24B | |
Net current asset value | 740.76M | 933.65M | 933.65M | 1.12B | 1.12B | |
Invested capital | 0.08 | 0.02 | 0.09 | 0.02 | 0.08 | |
Average receivables | 0 | 396.83M | 793.66M | 788.72M | 783.77M | |
Average payables | 0 | 386.15M | 389.53M | 396.51M | 403.5M | |
Average inventory | 0 | 594.33M | 598.04M | 586.52M | 574.99M | |
Days sales outstanding | 0 | 90.77 | 90.77 | 93.1 | 93.1 | |
Days payables outstanding | 0 | 65.17 | 65.17 | 71.94 | 71.94 | |
Days of inventory on hand | 0 | 100.05 | 100.05 | 102.51 | 102.51 | |
Receivables turnover | 0 | 0.99 | 0.99 | 0.97 | 0.97 | |
Payables turnover | 0 | 1.38 | 1.38 | 1.25 | 1.25 | |
Inventory turnover | 0 | 0.9 | 0.9 | 0.88 | 0.88 | |
ROE | 0 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex per share | 0 | -0.01 | -0.01 | -0.08 | -0.08 |
1571.HK Frequently Asked Questions
What is Xin Point Holdings Limited stock symbol ?
Xin Point Holdings Limited is a CN stock and trading under the symbol 1571.HK
What is Xin Point Holdings Limited stock quote today ?
Xin Point Holdings Limited stock price is $3.17 today.
Is Xin Point Holdings Limited stock public?
Yes, Xin Point Holdings Limited is a publicly traded company.